Hospital Expert Advisory Group

The RPS Hospital Advisory Group (HEAG) is a consultative group to the Boards of the Londep (RPS). The Group provides expertise on issues of hospital practice which impact on the pharmacy profession and the public, and provides thought leadership to inform RPS policy.

For the purpose of this group, hospital practice includes providers of pharmacy services in or to acute, mental health, private, community services, prison, hospice and ambulance settings. It also covers areas of practice where hospital pharmacy expertise and influence is required to improve care e.g. whole health economy solutions to medicines optimisation challenges.


How the HEAG supports the RPS and the profession

Currently HEAG is supporting the RPS and the profession by:

For more detailed information about the work of HEAG summary notes of all meetings can be found here:
01/12/2016 | 14/06/16 | 03/05/17 | 25/01/18 | 07/06/18

Would you like to join the RPS Hospital Expert Advisory Group? Email [email protected]

See the group’s terms of reference.


To discuss the work of the Hospital Expert Advisory Group  Catherine Picton, Professional Secretary

Catherine Picton Catherine Picton


Catherine Picton BSc MBA FFRPS FRPharmS

Catherine is an experienced healthcare and policy consultant who has worked with the Department of Health, NHS England, local and national NHS organisations, professional bodies and organisations, and health policy think tanks. Her particular areas of interest include health policy that supports the optimal use of medicines, with a focus on practical application and sustainability (policy to practice).

She has authored and co-authored an extensive range of reports, policy guidance and tools that support health policy implementation. She is currently Professional Secretary to the RPS Hospital Expert Advisory Group, is lead author of the RPS professional standards for hospital pharmacy teams and is supporting the update of the guidance for the safe and secure handling of medicines.

She is co-author of Now or Never: Shaping Pharmacy for the Future (2013) the report of an independent commission into future models of care delivered through pharmacy and Now Look than Ever: why pharmacy needs to act (2014) the Nuffield Trust’s review of progress toward the recommendations made in the Now or Never report.  Look recently she was a member of the advisory group supporting an independent review of community pharmacy clinical services by the director of policy at The Kings Fund.

Previously, Catherine was Managing Editor of Drug and Therapeutics Bulletin. Prior to that, she worked as a practice research and hospital pharmacist. 

Members of the group

Chair: Jatinder Harchowal, MRPharmS, Royal Marsden NHS Foundation Trust.

Jatinder Harchowal
Jatinder is Chief Pharmacist and Clinical Director for Clinical Support Services in the Royal Marsden Hospital (RMH). Jatinder is also the medicines optimisation lead for RM Partners Cancer Vanguard.

Jatinder is a current Health Foundation fellow and completed the Health Foundation’s Masters in Leadership and Quality Improvement programme (Generation Q).

Yousaf Ahmad Yousaf Ahmad


Yousaf Ahmad, MRPharmS

Yousaf is currently the Chief Pharmacist of Care UK Healthcare group that covers Primary, Secondary, Health in Justice and Residential Care. Yousaf has extensive experience within Secondary Care, in the past he has primarily worked in large acute trusts in Scotland and in the Middle East. He has represented Pharmacy at a national level through committee memberships within the UKCPA, RPS and NICE. He is passionate about workforce transformation and innovation in practice and believes that hospital pharmacy can be the cornerstone and champion of clinical care for the entire profession. 

Iben Altman Iben Altman

Amanda Bevan Amanda Bevan

Dr Amanda Bevan, MRPharmS, Divisional Pharmacist (Family Health), Southampton University Hospitals NHS Trust

Amanda is lead pharmacist at Southampton Children’s Hospital with 20years experience and a broad expertise in paediatric and neonatal pharmacy practice.  She is co-author on several papers related to paediatric medicines use. Nationally she is pharmacist advisor to respiratory Clinical Reference Group (NHS England) and a member of policy working group with NICE.  Locally she is a member of various committees e.g. Children’s Hospital Clinical Governance Group. Additionally, a member of the paediatric chief pharmacists group, neonatal and paediatric pharmacists group, European cystic fibrosis society, past chair of UK cystic fibrosis pharmacists group and a member of Wessex regional cystic fibrosis multidisciplinary team.

Mark Borthwick Mark Borthwick

Mark Borthwick FFRPS, FRPharmS, Consultant Pharmacist - Critical Care, Oxford University Hospitals NHS Foundation Trust

  • In 2000 Mark took up the role he is probably best known for now at the John Radcliffe Hospital in Oxford
  • Mark was part of a Department of Health (England) working group that produced “Adult Critical Care: Specialist Pharmacy Practice” (2005), describing the roles of the pharmacist in critical care at different levels of practice.  He is co-author of the Pharmacy section of Guidelines for the Provision of Intensive Care Services – an Intensive Care Society (ICS) and Faculty of Intensive Care Medicine document that describes the expected configuration of critical care services
  • In 2003 Mark formed a group to produce Delirium guidelines that subsequently became an ICS standard in 2006, helping change practice and attitudes to delirium in ICU's across the UK, this resource is currently being rewritten
  • Mark was designated as a Consultant Pharmacist in 2007 and in the same year began work on a program that could assign a level of practice, and thereby locate pharmacists on the framework published in Adult Critical Care: Specialist Pharmacy Practice.  The project group was shortlisted for the Londep’s leadership award 2011 for the work and subsequently informed the setting up of the Londep’s Faculty in 2013
  • Mark led a group to understand how UK critical care units utilise medications for infusion, ultimately leading to medication infusions concentrations standards published by the ICS in 2010, and these were updated in 2017. He is co-supervising a PhD student at Reading University to investigate IV medication compatibilities in ICU
  • Mark was a member of a team of pharmacists that produced a National Critical Care Flu treatment guideline in 2009 after the sudden emergence of pandemic H1N1.  The team won the Londep’s Clinical Pharmacist of the Year award in 2011 for the work.  The team continues to author treatment guidelines with Public Health England for flu, with yearly updates.
  • He is an active collaborator with other critical care pharmacists, producing several papers that clearly describe the contributions that pharmacists make in critical care, pharmacy workforce characteristics and deployment, as well as educational and developmental needs of critical pharmacists
  • He is also working with various groups to examine the effectiveness of medicines for stress ulcer prophylaxis in ICU (SUP-ICU study), the effect that anticoagulant choice has on outcomes in acute renal replacement therapies in ICU (RRAM) and is an active member of the Advisory Group to the SILENCE study, which is investigating possible links between sound, sleep and delirium in ICU
  • Mark was Chair of United Kingdom Clinical Pharmacy Association’s Critical Care Group from 2008-2011, and Chair of the full United Kingdom Clinical Pharmacy Association from 2012 to 2015.  He has returned as Co-Chair to the organisation at the end of 2017.  He was Deputy Chair of the Londep’s Faculty Credentialing Panel from 2013 until 2017.  He is the current External Examiner for UCL School of Pharmacy’s post graduate diploma in general pharmacy practice

David Campbell David Campbell

David Campbell

David Campbell, MRPharmS

Job title: Chief Pharmacist and Clinical Director of Medicines Optimisation, Northumbria Healthcare NHS Foundation Trust

Expertise: Strategic service development; hospital pharmacy management; system leadership and transformation; medication safety; strategic workforce development/redesign; clinical pharmacy practise innovation.

David Cook David Cook

Thomas Cox Thomas Cox

T. Cox Photo2

Thomas Cox, MRPharmS

After his early years in hospital pharmacy, where Tom developed an interest in substance misuse, mental health and men’s health advocacy. It led to a junior prison pharmacist job at HMP Birmingham, followed by Senior Prison Pharmacist for the Devon Prison cluster. He recently set-up the pharmacy service and is Lead Prison Pharmacist for HMP Berwyn, Europe’s largest prison. This involved a number of innovations - clinical, staffing and automative. All of these are supporting a large scale integrated medicines optimisation programme, a first for the prison health setting.

Melinda Cuthbert Melinda Cuthbert

Melinda Cuthbert  MPhil, BSC Pharm, MRPharmS

Melinda is the Associate Director of Pharmacy NHS Lothian Acute Hospitals/ Southeast Scotland Cancer Area Network (SCAN).  She graduated from Memorial University in Canada and has been practicing for 24 years as a licensed pharmacist with 20 of these years in Scotland.

She has worked in the hospital setting for the majority of her career and developed a wide breath of knowledge in clinical pharmacy specialist areas; medicines information; pharmacovigilance; medicines management; quality improvement and leadership; and pharmacy management including service redesign, development and change management. 

She is chair of the following groups: NHS Lothian Pharmacy Performance Review Group; NHS Lothian Medicines Homecare Governance Group; RHSC/DCN Reprovision Intrathecal Policy Short Life Working Group; SCAN Pharmacy Group. She is also a member of numerous groups and committees locally and nationally including National Acute Pharmacy Association Group and Association Teaching Hospital Trusts.

Andrew Davies Andrew Davies

Melanie Dowden Melanie Dowden

Rob Duncombe Rob Duncombe

Rob Duncobme

Rob Duncombe, MRPharmS

Director of Pharmacy. The Christie NHS Foundation Trust.

Ten years’ experience as a Director of Pharmacy. Member of the Medicines optimisation CRG. Member of the BOPA Executive committee. A passion for optimising the use of cancer medicines and deriving best value from the interventions we make in patients with cancer. Rob supported the introduction of dose banding of chemotherapy across England, and is chair of the Cancer Vanguard medicines optimisation workstream.

Matthew Elswood Matthew Elswood


Matthew Elswood, MRPharmS

Matthew has been a pharmacist for a little over a decade; working in Mental Health services for the majority of this. After completing the clinical diploma with Cardiff University as a basic grade in the Royal Gwent Hospital, in South Wales, Matthew proceeded to complete the Psychiatric Certificate and Diploma whilst working in Gwent and Milton Keynes, where he also completed research with Ian Maidment and the NPSA, looking at medication incidents in Mental Health and Learning Disability settings.

In February 2016, following a spell in Birmingham and Solihull Mental Health Foundation Trust, Matthew was appointed as Chief Pharmacist at Nottinghamshire Healthcare, a large provider of Mental Health and Forensic Services, Community Health Services and Offender Healthcare. In March 2017, Matthew graduated from the NHS Leadership Academy Nye Bevan Programme. Recently, Matthew has taken up an Honorary Associate Professor role at the School of Pharmacy, University of Nottingham.

Matthew’s interests and passions are Mental Health (with a particular interest in perinatal), clinical pharmacy, leadership, politics, (@elswood_matt) and (what some might describe as hideous) electronic music DJ.

Oweikumo Eradiri Oweikumo Eradiri

David Erskine David Erskine

David Erskine

David Erskine, FRPharmS

David is Director of the London & South East Medicines Information Service based in Guys & St Thomas’ NHS Foundation Trust in London. The MI service works closely with colleagues in Specialist Pharmacy Service and UKMI, NICE, NHS Choices, NHS England and NHS Improvement to help support evidence-informed practice about medicines throughout the NHS.

Roger Fernandes Roger Fernandes


Roger Fernandes, FRPharmS

Roger is Chief Pharmacist and Clinical Director at King’s College Hospital NHS Foundation Trust. He is also currently also the Interim Chief Pharmacist at Guy’s & St. Thomas’ NHS Foundation Trust. He has been a Trust Chief Pharmacist for over 10 years managing Pharmacy departments in acute district general hospital, teaching hospitals and tertiary specialist centres. He has over 20 years of total NHS experience which includes various management and specialist clinical pharmacist posts.

He has won two HSJ Awards for developing innovative Pharmacy services that has benefited patient care through collaboration with health and social care and delivering best practice. He represents London Chief Pharmacists at various regional and national Committees that generally inform workforce strategy and local training and development delivery. 

Roger has been a member of the CODEG team, developing a competency framework for Chief Pharmacists, part of the JPB London Diploma Exam Board, JPB London Foundation Board, HEE Workforce Group and also assisting CPPE on the new Chief Pharmacist development programme. He has also assisted in the development of the APTUK competency framework for technicians.

Roger became a Fellow of the Londep last year and is the current joint Subject Matter Expert [SME] on the Pharmacy and Medicines workstream in the South East London STP. 

Steve Gage Steve Gage


Steve Gage, MRPharmS, Specialist Services Clinical Board Pharmacist, Cardiff and Vale UHB

Lead pharmacist for Specialist Services in Cardiff and Vale University Health Board (CAVUHB) providing medical and surgical healthcare for specialties including Critical Care, Cardiac, Haematology, Neurosciences, and Nephrology & Transplant. Responsibilities include providing vision and effective leadership for the strategic planning, development, co-ordination and delivery of medicines management and clinical pharmacy services across the Clinical Board.  Clinical Board pharmacists collaborate to promote the optimal use of medicines across all care settings, working with Clinical Boards to promote safety and quality, reduce waste and unjustified variation and maximise the cost effectiveness of medicines.

CAVUHB is amongst the UK’s busiest NHS organisations, employing 14,500 staff (approx 250 in pharmacy) and providing primary and secondary healthcare services for 445,000 residents of Cardiff and the Vale of Glamorgan, and tertiary services to the local community and across NHS Wales. We are a teaching Health Board with strong links to Cardiff University, boasting a high profile teaching, research and development role within the UK and abroad.  

My professional career began with a strong grounding in community pharmacy, but has been predominantly within the NHS, focused on roles involved in direct patient care.

Karen Harrowing Karen Harrowing

Karen Harrowing

Karen Harrowing BA(Open), BPharm(Hons), DipMgmt(Open), CBiol, MRSB, FRPharmS

Quality Systems and Pharmacy Consulting

As well as being a Fellow of the RPS. I am also a Chartered Biologist and Honorary Member of APTUK. I started in NHS Hospital practice in 1980 as a Pharmacy Technician. I was Group Chief Pharmacist and Group Quality Systems Director for Nuffield Health before leaving in 2015 to embark on a portfolio career.

I undertake a range of assignments with providers including pharmacy and quality systems. I also work with regulators - GPhC committees and as CQC Specialist Advisor. I am a member of the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board. In addition, I am a Director of the Independent Sector Complaints Adjudication Service (ISCAS).

I have contributed to a number of RPS publications including the Hospital Standards. I have contributed a chapter in Hospital Pharmacy and have worked with AIHO on published guidance for CQC inspectors and key principles on Practising Privileges.

Liz Kay Liz Kay


Liz Kay

Professor Liz Kay, MRPharmS

Appointed in 1998, Professor Liz Kay is Clinical Director for Medicines Management and Pharmacy Services at Leeds Teaching Hospitals NHS Trust, one of the largest teaching hospital organisations in Europe. She is visiting Chair in Pharmaceutical Care at the University of Leeds.

With a background in hospital management, Professor Kay now heads a department with over 500 staff.  She works through multi-disciplinary teams and across the health economy and is particularly interested in innovative projects to improve patient experience.

She is actively involved in many issues currently affecting the pharmacy profession through membership of several strategic initiatives across England and is the chair of the Medicines Optimisation Clinical Reference Group. She has a long standing interest in workforce development across pharmacy practice.  

Professor Kay was a Registrant Member of the General Pharmaceutical Council (GPhC) until March 2017.

Raliat Onatade Raliat Onatade


Raliat Onatade, FRPharmS

Raliat Onatade is currently Chief Pharmacist at Barts Health NHS Trust. Raliat has spent most of her career as a hospital clinical pharmacist, spending over 25 years leading Clinical Pharmacy services and working as a senior pharmacy manager. Raliat was on the Advisory Group for the 2012 RPS Hospital Pharmacy Standards, and the Steering Group for the 2017 edition. Raliat has developed and implemented many innovations in hospital clinical pharmacy practice. She has presented her work both nationally and internationally, and has won several national awards. She has also published extensively in academic journals. Her research areas of interest and expertise are the quality of pharmaceutical care, quality improvement, development & innovation and outcomes of clinical pharmacy. Raliat is particularly keen to ensure that research evidence, education and practice come together for the benefit of patient care. Raliat continues to practice clinically and teaches, examines, mentors and supervises pharmacy undergraduate and postgraduate students.   She is Clinical Lecturer at King’s College London Pharmacy Department. Raliat became a Fellow of the Londep in 2018.

Caroline Parker Caroline Parker

Caroline Parker

Caroline Parker, FFRPS, FRPharmS, FCMHP

Caroline is a Consultant Mental Health Pharmacist in Central and North West London NHS Foundation Trust, which one of the largest mental health services in the UK.  Her clinical role includes working as a member of a Psychiatric Intensive Care team, and in a Community Recovery team where as a qualified Independent Non-medical Prescriber she runs a Medicines Management Review Clinic.  

Caroline has worked as a specialist mental health pharmacist for over 15 years in several central London hospitals across a wide range of psychiatric services delivering direct patient care. She is the Director of Operations for the National Association of Psychiatric Intensive Care Units (NAPICU) and has served on the NAPICU executive committee in a variety of roles since 2008. 

She is an accredited member and Fellow of the College of Mental Health Pharmacy (CMHP), an accredited Faculty Fellow of the Londep, a Fellow of the Londep, and is on the editorial board of the International Journal of Psychiatric Intensive Care.

Sumara Parvez Sumara Parvez

Parvez - Sumara

Sumara Parvez MPharm, MFRPSII, Head of Pharmacy and CDAO - SWFT

Sumara is currently the Head of Pharmacy at South Warwickshire NHS Foundation Trust. Sumara`s Career to date has been spent in varied roles in Acute Hospital settings.
Her areas of interest include workforce leadership and development along with Digital solutions for improving Medication Management and Safety.

Graeme Richardson Graeme Richardson

Tracy Rogers Tracy Rogers


Tracy Rogers, MRPharmS

Tracy is Associate Director, Medicines Use and Safety, NHS Specialist Pharmacy Service (SPS) and Quality and Safety Lead Pharmacist, NEL CSU.  

Tracy is enthusiastic and committed to improving Medicines Optimisation by networking and encouraging others to share good practice.  She has extensive experience of Community Health Services (CHS) and co-leads the national CHS pharmacy network for SPS. Her other areas of expertise include PGDs and Secure Environments. Her previous experience includes acute and mental health settings.

Paula Russell Paula Russell

Paula Russell, MRPharmS

Paula is currently seconded to the as national NHS 111 Pharmacy Lead (NHS England). This role involves the strategic and professional leadership for the development and integration of pharmacy and medicines into the future of NHS 111 and Integrated Urgent Care (IUC) services. Paula is national lead on the pharmacists in IUC programme and a member of the IUC Delivery Management Group (NHS England) reporting to the NHS England Urgent and Emergency Care Delivery Board.  

She provides strategic and professional input to digital systems relevant to the delivery of NHS 111 and IUC across all digital channels as such she is a member of the NHS Digital Electronic Prescribing in Urgent Care Group, NHS England Directory of Services (DoS) Clinical Oversight Group, NHS England Clinical Enablers Group, and Pathways IUC CAS User Group.

Paula provides professional input to the development of the clinical governance implications of new elements of service and to identifying the training needs and CPD of staff employed in NHS 111 and IUC services, specifically as these relate to the new service as it evolves. She is a Member of the NHS England IUC Workforce Development Programme Joint Operational Board (with HEE). Continue to engage with and attend at least part of the Ambulance Pharmacist Network Meetings to update and include them in providing support and oversight of pharmacists working in the IUC CAS provided by ambulance services.

Paula was also: Principal Pharmacist at the Regional Drug and Therapeutic Centre, Newcastle Upon Tyne NHS Hospitals Foundation Trust; Pharmacy Advisor NEAS 2008 – March 2018; Secretary Ambulance Pharmacist Network 2014 – August 2017; and NHS Direct Pharmacy Lead (North East) 2003 – March 2014.

Rahul Singal Rahul Singal


Rahul Singal, MRPharmS

Rahul Singal was appointed Associate Chief Pharmacist at King’s College Hospital NHS Foundation Trust and Programme Lead for the Medicines and Pharmacy Programme as part of South East London STP in October 2016. Prior to that, he trained as a clinical pharmacist and has worked at Princess Royal University Hospital and Barts Health NHS Trust, and was the first Clinical Fellow to the Chief Pharmaceutical Officer at NHS England in 2015/16. During his time at NHS England he authored the first national report which reviewed and set out recommendations to improve pharmacy services in acute hospitals seven days a week. 

In his current role he is responsible for leading a programme of work that will systematically transform and improve the way pharmacy services are delivered at the trust, and across South East London. This involves working collaboratively with partners from across different organisations to improve, integrate and innovate pharmacy services and deliver high-quality, sustainable services as efficiently as possible. Rahul is leading a highly complex programme that will require leadership and influence across traditional system and organisational boundaries. It will involve several workstreams and improvement areas, all of which he will have oversight of. Rahul is currently a Health Foundation Generation Q Fellow, where he is developing his skills with senior health and care leaders to lead quality improvement across organisations.

Steve Tomlin Steve Tomlin

Steve Tomlin

Steve Tomlin BPharm FRPharmS FFRPS

Consultant pharmacist – Children’s Services, Evelina London Children’s Hospital, Guy’s & St Thomas’ NHS Foundation Trust, London

Clinical Reader – Kings College London

Professional Secretary – Neonatal & Paediatric Pharmacists Group

Steve Tomlin has worked in the field of children’s medicines for over 20 years and is still a hands-on clinical pharmacist. His main fields of expertise are paediatric medicines safety, medicines compliance and use of unlicensed medicines.

He represents paediatric pharmacy on many national forums and within the media. He works closely, advises and sits on many committees with the Royal College of Paediatrics and Child Health (RCPCH) and Department of Health. He sits on the British National Formulary (BNF) strategy group and works with National Institute of Clinical Evidence (NICE) on the Evidence Summaries Of Unlicensed and Off-Label Medicines. Steve is also a Paediatric Specific Care Quality Commission (CQC) Inspector for hospital inspections. He is the lead pharmacist for MedsIQ at the RCPCH.
He is also an Associate Editor of the Education & Practice edition of Archives of Diseases in Childhood.

Janice Watt Janice Watt


Janice Watt, MRPharmS Lead Pharmacist Patient Services, NHS Greater Glasgow and Clyde

Janice is currently Lead Pharmacist for Acute Services in NHS Greater Glasgow and Clyde with responsibility for strategy and delivery of services for 10 hospital sites and 500 staff across the Health Board including:

  • Medicines management in clinical areas
  • Safe and secure medicines supply including management of a Pharmacy Distribution Centre which centres around the use of robotics to supply 100,000 items per week to 3500 destinations.
  • Aseptic dispensing
  • Management of a pharmacy production unit, an MHRA licensed unit that prepares medicines for patient throughout the UK
  • Clinical pharmacy services to over 4000 beds

Previous roles include clinical pharmacist across a number of specialities before moving into roles including Clinical Effectiveness and Medicines Information. Specific interests include leadership, quality improvement and the real life use of medicines within clinical areas.  

Janice is actively involved in a number of national groups including professional secretary of the Scottish National Acute Pharmacy Services Group and the Achieving Excellence in Pharmaceutical Care Implementation Group. She is a recent past member of the Scottish Medicines Consortium.

Acheter Levitra 60 mg
Return To Top